Author

Max Dotson

Thermo Fisher Scientific (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Nicholas Putnam· 2 shared Nujhat Fatima· 2 shared Yongchang Ji· 2 shared Alison K. McClellan· 1 shared Alvin S. HaiD· 1 shared Austin HartmaniD· 1 shared Brian Rudolph ShyiD· 1 shared Christian H. Burns· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetics

Nicholas Putnam

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Ultra-large targeted DNA integrations in primary human cells

Courtney Kernick, Lauren Chow, Mikail Alejandro, Ke Li, Maxwell Gabriel Foisey, Xiaoyu Yang, Claire E. Hilburger, Johnathan Lu, Lujing Wu, Alison K. McClellan, Oliver Takacsi-Nagy, Rocco Brajenovic, Nicole E. Theberath, Emily Celallos Fuentes, Erin Lin, , Theodore L. Roth

This paper identifies methods to achieve ultra-large DNA integrations (>10 kb) in human cells with high efficiency using optimized templates and delivery strategies.

bioRxiv · Apr 9, 2026 · PreprintGenetics

Accelerating CAR T cell manufacturing with an automated next-day process

Moloud Ahmadi, Nicholas Putnam, Max Dotson, Danny Hayoun, Jasmine Padilla, Nujhat Fatima, Prajakta Bhanap, Gertrude Nonterah, Xavier de Mollerat du Jeu, Yongchang Ji

This study introduces an automated 24-hour CAR T cell manufacturing process that increases naive/stem-cell like T cells and cytotoxic activity, potentially improving therapy efficacy and patient access.

Current Research in Translational Medicine · Dec 7, 2024Peer-reviewedBioengineering